Privia Health Group, Inc. (NASDAQ:PRVA) Position Increased by Credit Suisse AG

Credit Suisse AG increased its stake in Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) by 8.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 69,832 shares of the company’s stock after acquiring an additional 5,170 shares during the period. Credit Suisse AG’s holdings in Privia Health Group were worth $2,378,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Assetmark Inc. lifted its holdings in shares of Privia Health Group by 119.4% in the 2nd quarter. Assetmark Inc. now owns 893 shares of the company’s stock worth $26,000 after purchasing an additional 486 shares during the last quarter. Signaturefd LLC bought a new stake in Privia Health Group during the 3rd quarter valued at $32,000. Nisa Investment Advisors LLC bought a new stake in Privia Health Group during the 2nd quarter valued at $46,000. Point72 Hong Kong Ltd bought a new stake in Privia Health Group during the 1st quarter valued at $47,000. Finally, Ameritas Investment Partners Inc. raised its stake in Privia Health Group by 111.5% during the 1st quarter. Ameritas Investment Partners Inc. now owns 3,251 shares of the company’s stock valued at $87,000 after acquiring an additional 1,714 shares in the last quarter. Institutional investors own 66.83% of the company’s stock.

Insider Activity at Privia Health Group

In related news, COO Parth Mehrotra sold 53,560 shares of Privia Health Group stock in a transaction on Tuesday, February 28th. The stock was sold at an average price of $28.13, for a total transaction of $1,506,642.80. Following the completion of the sale, the chief operating officer now owns 97,391 shares of the company’s stock, valued at $2,739,608.83. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, COO Parth Mehrotra sold 53,560 shares of Privia Health Group stock in a transaction on Tuesday, February 28th. The stock was sold at an average price of $28.13, for a total transaction of $1,506,642.80. Following the completion of the sale, the chief operating officer now owns 97,391 shares of the company’s stock, valued at $2,739,608.83. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director William M. Sullivan sold 18,153 shares of Privia Health Group stock in a transaction on Friday, February 3rd. The shares were sold at an average price of $26.57, for a total value of $482,325.21. Following the sale, the director now directly owns 5,790,624 shares of the company’s stock, valued at approximately $153,856,879.68. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 168,287 shares of company stock valued at $4,352,843. Insiders own 57.60% of the company’s stock.

Analyst Ratings Changes

Several brokerages have weighed in on PRVA. SVB Leerink cut their target price on Privia Health Group from $46.00 to $39.00 and set an “outperform” rating on the stock in a research note on Friday, November 11th. Piper Sandler decreased their target price on Privia Health Group to $42.00 in a report on Thursday, November 17th. Canaccord Genuity Group decreased their target price on Privia Health Group from $50.00 to $43.00 in a report on Friday, November 11th. BTIG Research decreased their target price on Privia Health Group from $45.00 to $40.00 in a report on Monday, January 9th. Finally, Canaccord Genuity Group decreased their target price on Privia Health Group from $50.00 to $43.00 and set a “buy” rating on the stock in a report on Friday, November 11th. Thirteen analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $38.93.

Privia Health Group Trading Up 2.1 %

PRVA opened at $28.71 on Friday. The stock has a market cap of $3.30 billion, a price-to-earnings ratio of -261.00, a PEG ratio of 12.28 and a beta of 0.79. Privia Health Group, Inc. has a 1 year low of $17.99 and a 1 year high of $44.64. The stock has a fifty day moving average price of $25.67 and a 200 day moving average price of $29.67.

Privia Health Group Company Profile

(Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.